Finland· FI-REL-REL36989

Ioa

A nomegestrol und estradiol product containing nomegestrol acetate + estradiol hemihydrate, registered in Finland by Merck Sharp & Dohme Limited. The same ATC class is registered in 10 of our 19 countries.

ATC G03AA14

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedIoaATCG03AA14REGISTER NO.FI-REL-REL36989PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Nomegestrol und estradiol is registered in 10 of 19 countries.

Countries holding a registration under ATC G03AA14 (nomegestrol und estradiol), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Nomegestrol und estradiol · ATC G03AA14

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Nomegestrol acetate + Estradiol hemihydrate
Manufacturer
Merck Sharp & Dohme Limited
Country
Finland (FI)
ATC code
G03AA14
ATC class
Nomegestrol und Estradiol
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

29 interactions on record for nomegestrol und estradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Nomegestrol und estradiol · interactions on record

29 records

29 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Nomegestrol und estradiol in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nomegestrol und estradiol products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Italy · Naemis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/27415186-4a8a-4f7a-9009-173a47d6a165
GET /v1/drugs/27415186-4a8a-4f7a-9009-173a47d6a165?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "tabletti, kalvopäällysteinen",
  "route": null,
  "ddd_unit": "ED",
  "strength": "2.5 mg / 1.5 mg",
  "atc_label": "nomegestroli ja estradioli",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/11/689/001-002",
  "fimea_rel_id": "REL36989",
  "authorised_at": "2011-11-16"
}

See everything about nomegestrol und estradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.